amphetamine has been researched along with bibp 3226 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harro, J; Kask, A | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Liao, JM; Yu, CH | 1 |
2 other study(ies) available for amphetamine and bibp 3226
| Article | Year |
|---|---|
Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Central Nervous System Stimulants; Dopamine Agonists; Injections, Intraventricular; Injections, Subcutaneous; Male; Microinjections; Motor Activity; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Appetite; Arginine; Chromatin Immunoprecipitation; Feeding Behavior; Gene Knockdown Techniques; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Transcription Factor AP-1 | 2013 |